Jushi Holdings Past Earnings Performance
Past criteria checks 0/6
Jushi Holdings has been growing earnings at an average annual rate of 14.4%, while the Pharmaceuticals industry saw earnings growing at 9.4% annually. Revenues have been growing at an average rate of 7.5% per year.
Key information
14.45%
Earnings growth rate
24.78%
EPS growth rate
| Pharmaceuticals Industry Growth | 5.95% |
| Revenue growth rate | 7.51% |
| Return on equity | n/a |
| Net Margin | -26.90% |
| Last Earnings Update | 31 Mar 2026 |
Recent past performance updates
Recent updates
JUSH.F: DEA Registration Pathway Will Support Stronger Future Earnings Multiple
Analysts have reiterated a $1.50 price target for Jushi Holdings, with slightly refined assumptions around discount rate, revenue growth, profit margin and future P/E that keep their overall valuation view broadly unchanged. What's in the News Jushi Holdings submitted applications to the U.S. Drug Enforcement Administration for registration of certain state licensed medical marijuana operations under the federal framework that follows the rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.
Rescheduling Uncertainty And Heavy Debt Will Pressure Cannabis Expansion Before Potential Upside
Catalysts About Jushi Holdings Jushi Holdings operates state licensed cannabis cultivation, processing and retail facilities across several U.S. markets. What are the underlying business or industry changes driving this perspective?JUSH.F: Higher Revenue Outlook Will Support Stronger Earnings Multiple
Analysts now see fair value for Jushi Holdings at $1.50, compared with the prior $1.00. This reflects updated assumptions for revenue growth, profit margins, discount rate, and future P/E that shift their risk and earnings outlook for the stock.
Adult Use Legalization And Rescheduling Will Reshape Long Term Prospects For This Cannabis Operator
Catalysts About Jushi Holdings Jushi Holdings is a vertically integrated cannabis company focused on retail, cultivation and processing across several U.S. medical and emerging adult use markets. What are the underlying business or industry changes driving this perspective?
Pennsylvania And Virginia Retail And Canopy Expansion Will Open Markets
Expanding retail and canopy space aims to enhance revenue, anticipating market growth from potential adult-use cannabis legalization.Revenue & Expenses Breakdown
How Jushi Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 26 | 265 | -71 | 111 | 0 |
| 31 Dec 25 | 263 | -69 | 109 | 0 |
| 30 Sep 25 | 260 | -66 | 105 | 0 |
| 30 Jun 25 | 256 | -58 | 106 | 0 |
| 31 Mar 25 | 256 | -47 | 105 | 0 |
| 31 Dec 24 | 258 | -49 | 107 | 0 |
| 30 Sep 24 | 259 | -54 | 101 | 0 |
| 30 Jun 24 | 263 | -59 | 103 | 0 |
| 31 Mar 24 | 265 | -71 | 106 | 0 |
| 31 Dec 23 | 269 | -65 | 110 | 0 |
| 30 Sep 23 | 278 | -188 | 125 | 0 |
| 30 Jun 23 | 286 | -221 | 139 | 0 |
| 31 Mar 23 | 292 | -195 | 155 | 0 |
| 31 Dec 22 | 284 | -202 | 155 | 0 |
| 30 Sep 22 | 273 | -53 | 151 | 0 |
| 30 Jun 22 | 255 | 40 | 139 | 0 |
| 31 Mar 22 | 230 | 31 | 122 | 0 |
| 31 Dec 21 | 209 | 20 | 112 | 0 |
| 30 Sep 21 | 176 | -144 | 85 | 0 |
| 30 Jun 21 | 147 | -213 | 69 | 0 |
| 31 Mar 21 | 114 | -225 | 56 | 0 |
| 31 Dec 20 | 81 | -211 | 41 | 0 |
| 30 Sep 20 | 55 | -71 | 43 | 0 |
| 30 Jun 20 | 33 | -37 | 44 | 0 |
| 31 Mar 20 | 18 | -40 | 42 | 0 |
| 31 Dec 19 | 10 | -31 | 35 | 0 |
| 30 Sep 19 | 5 | -19 | 28 | 0 |
| 30 Jun 19 | 1 | -25 | 21 | 0 |
| 31 Mar 19 | 1 | -15 | 13 | 0 |
| 31 Dec 18 | 1 | -20 | 11 | 0 |
Quality Earnings: JUSH.F is currently unprofitable.
Growing Profit Margin: JUSH.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: JUSH.F is unprofitable, but has reduced losses over the past 5 years at a rate of 14.4% per year.
Accelerating Growth: Unable to compare JUSH.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: JUSH.F is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-4.8%).
Return on Equity
High ROE: JUSH.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/17 19:15 |
| End of Day Share Price | 2026/06/17 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Jushi Holdings Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Frederico Yokota Choucair Gomes | ATB Cormark |
| Luke Hannan | Canaccord Genuity |
| Sonny Randhawa | Seaport Research Partners |